Rigel Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report

Rigel Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease mechanisms. The company’s lead product, the US FDA approved Tavalisse (fostamatinib disodium hexahydrate), is an oral spleen tyrosine kinase inhibitor to treat adult patients with chronic immune thrombocytopenia. Rigel is also evaluating Fostamatinib for autoimmune hemolytic anemia and IgA nephropathy in Phase II trials. The company has partnered clinical programs with Aclaris, BerGenBio, Daiichi, AstraZeneca, Kissei, Grifols, Merck, Novartis and Bristol-Myers Squibb. Rigel is headquartered in South San Francisco, California, the US.

Scope

  • Detailed information on Rigel Pharmaceuticals Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Rigel Pharmaceuticals Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Rigel Pharmaceuticals Inc including a breakdown and examination of key business segments
  • News about Rigel Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Rigel Pharmaceuticals Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Rigel Pharmaceuticals Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Rigel Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Novartis AG

Momenta Pharmaceuticals Inc

Gilead Sciences Inc

Genentech Inc

Emergent BioSolutions Inc

Amgen Inc

AbbVie Inc

Novartis AG

Momenta Pharmaceuticals Inc

Gilead Sciences Inc

Genentech Inc

Emergent BioSolutions Inc

Amgen Inc

AbbVie Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Rigel Pharmaceuticals Inc - Key Facts

Rigel ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Rigel Pharmaceuticals Inc - Key Facts

Rigel Pharmaceuticals Inc - Key Employees

Rigel Pharmaceuticals Inc - Key Employee Biographies

Rigel Pharmaceuticals Inc - Major Products and Services

Rigel Pharmaceuticals Inc - History

Rigel Pharmaceuticals Inc - Company Statement

Rigel Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Section 2 – Company Analysis

Company Overview

Rigel Pharmaceuticals Inc - Business Description

Rigel Pharmaceuticals Inc - Corporate Strategy

Rigel Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Rigel Pharmaceuticals Inc - Strengths

Rigel Pharmaceuticals Inc - Weaknesses

Rigel Pharmaceuticals Inc - Opportunities

Rigel Pharmaceuticals Inc - Threats

Rigel Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Rigel Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 26, 2019: Rigel welcomes Jane Wasman to board of directors

Feb 28, 2019: Rigel reports fourth quarter and full year 2018 financial results and provides company update

Nov 06, 2018: Rigel announces third quarter 2018 financial results and provides company update

Aug 08, 2018: Rigel Pharmaceutical reports second quarter 2018 financial results

May 01, 2018: Rigel Reports First Quarter 2018 Financial Results

Mar 06, 2018: Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Rigel Pharmaceuticals Inc, Key Facts

Rigel Pharmaceuticals Inc, Key Employees

Rigel Pharmaceuticals Inc, Key Employee Biographies

Rigel Pharmaceuticals Inc, Major Products and ...

List of Tables

Rigel Pharmaceuticals Inc, Key Facts

Rigel Pharmaceuticals Inc, Key Employees

Rigel Pharmaceuticals Inc, Key Employee Biographies

Rigel Pharmaceuticals Inc, Major Products and Services

Rigel Pharmaceuticals Inc, History

Rigel Pharmaceuticals Inc, Key Competitors

Rigel Pharmaceuticals Inc, Ratios based on current share price

Rigel Pharmaceuticals Inc, Annual Ratios

Rigel Pharmaceuticals Inc, Annual Ratios (Cont...1)

Rigel Pharmaceuticals Inc, Interim Ratios

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Rigel Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Rigel Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Rigel Pharmaceuticals Inc, Ratio Charts

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Rigel Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Rigel Pharmaceuticals Inc, Ratio Charts

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Rigel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports